Jackson Square Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$308K Buy
+2,069
New +$290K 0.05% 124
2026
Q2
– Sell
-18,785
Closed -$2.62M – 146
2026
Q1
$2.62M Buy
18,785
+10,334
+122% +$1.45M 0.55% 46
2025
Q4
$1.04M Buy
+8,451
New +$1.03M 0.21% 70
2025
Q3
– Sell
-6,850
Closed -$760K – 152
2025
Q2
$760K Sell
6,850
-1,161
-14% -$124K 0.17% 93
2025
Q1
$898K Buy
8,011
+5,762
+256% +$595K 0.29% 66
2024
Q4
$208K Buy
+2,249
New +$202K 0.05% 141
2024
Q2
– Sell
-14,192
Closed -$1.04M – 138
2024
Q1
$1.04M Sell
14,192
-137
-1% -$10.5K 0.27% 67
2023
Q4
$1.16M Buy
14,329
+51
+0.4% +$3.97K 0.37% 55
2023
Q3
$1.07M Buy
14,278
+638
+5% +$49.1K 0.43% 47
2023
Q2
$1.05M Buy
13,640
+199
+1% +$15.9K 0.42% 53
2023
Q1
$1.12M Buy
13,441
+185
+1% +$15.3K 0.5% 48
2022
Q4
$1.14M Buy
+13,256
New +$1.05M 0.54% 50
2020
Q4
– Sell
-860
Closed -$54K – 216
2020
Q3
$54K Hold
860
– – 0.02% 174
2020
Q2
$66K Hold
860
– – 0.03% 151
2020
Q1
$64K Hold
860
– – 0.05% 111
2019
Q4
$56K Buy
+860
New +$56K 0.03% 147

Other funds holding GILD

Jackson Square Capital's GILD Position: Q3 2026 in Review

Jackson Square Capital opened a new position in Gilead Sciences (GILD) in Q3 2026: 2,069 shares worth $308K. The stake represents 0.05% of the portfolio and ranks #124 among its holdings. This is a return to the name: Jackson Square Capital previously reported a position in GILD as recently as Q1 2026.

Jackson Square Capital first reported a position in GILD in Q4 2019 and has held it in 16 quarters since. The position peaked at $2.62M in Q1 2026. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Jackson Square Capital held 2,069 shares of Gilead Sciences worth $308K as of Q3 2026.
  • Gilead Sciences was a new Jackson Square Capital position in Q3 2026.
  • Gilead Sciences made up 0.05% of Jackson Square Capital's portfolio in Q3 2026, its #124 holding.
  • Jackson Square Capital first reported a position in Gilead Sciences in Q4 2019 and has held it in 16 quarters since.
  • Jackson Square Capital's Gilead Sciences position peaked at $2.62M in Q1 2026.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Jackson Square Capital's 13F filing for Q3 2026, filed 19 Oct 2026.